Search results for "kinetics"

showing 10 items of 2224 documents

Nonlinearities in amoxycillin pharmacokinetics. II. Absorption studies in the rat.

1992

Most factors influencing amoxycillin oral absorption are, even today, unknown. Since many dosage schedules have been shown to lead to incomplete absorption, it would be desirable to find a suitable animal model where these factors could be studied in depth. In this paper, it is shown that, in the rat, plasma level curves obtained after oral doses of 7 and 28 mg kg-1 are poorly fitted using first-order absorption kinetics and that the best fit is obtained through the use of an input equation combining zero and first-order kinetics. In contrast, plasma level curves found after intraduodenal administration of amoxycillin solutions (7 mg kg-1) are well fitted by first-order input kinetics. It w…

PharmacologyAbsorption (pharmacology)MaleChemistryKineticsPharmaceutical ScienceAmoxicillinBiological AvailabilityRats Inbred StrainsGeneral MedicinePharmacologyAmoxicillinModels BiologicalIntestinal absorptionBioavailabilityRatsPharmacokineticsIntestinal AbsorptionOral administrationCurve fittingmedicineAnimalsPharmacology (medical)medicine.drugBiopharmaceuticsdrug disposition
researchProduct

Modeling dynamics of paroxysmal activity and pharmacokinetics of GABAA receptor ligands during their direct application into their biophase of action

2010

PharmacologyAction (philosophy)PharmacokineticsGABAA receptorChemistryGeneral MedicinePharmacologyPharmacological Reports
researchProduct

Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity

2003

Aims  The aim of this study was to assess the influence of concomitant caffeine intake on the pharmacokinetics of oral melatonin, a probe drug for CYP1A2 activity. Methods  Twelve healthy subjects, six smokers and six nonsmokers, were given melatonin (6 mg) either alone or in combination with caffeine (3 × 200 mg). Blood samples for the analysis of melatonin or caffeine and paraxanthine were taken from 1 h before until 6 h after intake of melatonin. Subjects were genotyped with respect to the CYP1A2*1F (C734A) polymorphism. Results  When caffeine was coadministered the Cmax and AUC of melatonin were increased on average by 142% (P = 0.001, confidence interval on the difference 44, 80%) and …

PharmacologyChemistryCYP1A2CmaxPharmacologyCrossover studyBioavailabilityMelatoninchemistry.chemical_compoundPharmacokineticsmedicinePharmacology (medical)CaffeineParaxanthinemedicine.drugBritish Journal of Clinical Pharmacology
researchProduct

INTESTINAL ABSORPTION KINETICS OF AMIODARONE IN RAT SMALL INTESTINE

1997

Amiodarone is a widely used antiarrhythmic agent with highly variable therapeutic effects. These seem to be related, at least in part, to the pharmacokinetics of the drug and particularly to some features of its gastrointestinal absorption process. The drug exhibits physico-chemical properties highly suitable for diffusion across lipophilic absorbing membranes, but its low aqueous solubility can act as the rate limiting step for absorption, making the process erratic and variable. In order to gain an insight into the intestinal absorption mechanism of the drug and detect possible non-linearities, a series of experiments using a classical rat gut in situ preparation were carried out with thr…

PharmacologyChromatographyChemistrymedicine.medical_treatmentAmiodarone HydrochloridePharmaceutical ScienceGeneral MedicineAbsorption (skin)Antiarrhythmic agentAmiodaroneIntestinal absorptionMembranePulmonary surfactantPharmacokineticsBiochemistrymedicinePharmacology (medical)medicine.drugBiopharmaceutics & Drug Disposition
researchProduct

In Situ Study of the Effect of Naringin, Talinolol and Protein-Energy Undernutrition on Intestinal Absorption of Saquinavir in Rats

2011

To study the potential interactions of naringin (NAR), talinolol (TAL) and protein-energy undernutrition (PEU) in the absorption process of saquinavir (SQV), perfusion experiments were performed in the small intestine of rats at different SQV concentrations. The results obtained demonstrated that SQV intestinal absorption was described by simultaneous passive diffusion (kdif = 3.44 hr) and saturable absorption (Vma = 127.31 lM ⁄ hr; Kma =1 0.50lM) together with a capacity-limited efflux (Vms = 270.53 lM ⁄ hr; Kms =2 3.44lM). The competitive inhibition constants of NAR on the SQV input and efflux processes were (IC50)a =3 .98l Ma nd(IC50)s = 5.00 lM, respectively. NAR significantly decreased…

PharmacologyChromatographyGeneral MedicineAbsorption (skin)PharmacologyToxicologyIntestinal absorptionSmall intestinechemistry.chemical_compoundmedicine.anatomical_structurechemistryPharmacokineticsmedicineNaringinSaquinavirIC50medicine.drugTalinololBasic & Clinical Pharmacology & Toxicology
researchProduct

Mono- and diglucuronide formation from benzo[a]pyrene and chrysene diphenols by AHH-1 cell-expressed UDP-glucuronosyltransferase UGT1A7

1999

Polycyclic aromatic hydrocarbon (PAH)-type compounds induce at least two rat UDP-glucuronosyltransferase isoforms, UGT1A6 and UGT1A7. Among the glucuronidation reactions of PAH metabolites studied, mono- and diglucuronide formation of benzo[a]pyrene and chrysene-3,6-diphenol showed the highest induction factors in rat liver microsomes. Availability of AHH-1 cells stably expressing UGT1A7 allowed us to study whether this PAH-inducible isoform could catalyze benzo[a]pyrene and chrysene-3,6-diphenol glucuronidation. It was found that UGT1A7 indeed catalyzed mono- and diglucuronide formation of both benzo[a]pyrene and chrysene 3,6-diphenols. V79 cell-expressed rat UGT1A6 also catalyzed these re…

PharmacologyChrysenechemistry.chemical_classificationStereochemistryMetaboliteGlucuronidationPolycyclic aromatic hydrocarbonGlucuronatesTransfectionBiochemistryChrysenesCell LineSubstrate SpecificityKineticschemistry.chemical_compoundPhenolschemistryBenzo(a)pyreneBenzo(a)pyrenepolycyclic compoundsPyrenePhenolsGlucuronosyltransferaseHymecromoneCarcinogenBiochemical Pharmacology
researchProduct

QRAR models for central nervous system drugs using biopartitioning micellar chromatography.

2002

The capability of biopartitioning Micellar Chromatography, BMC, to describe and estimate pharmacokinetic and pharmacodynamic parameters of central nervous system drugs is reviewed in this article. BMC is a mode of micellar liquid chromatography, MLC, that uses micellar mobile phases of Brij35 (polyoxyethilene(23) lauryl ether) prepared in physiological conditions (pH, ionic strength). The retention of a drug in this system depends on its hydrophobic, electronic and steric properties, which also determine its biological activity. The results of BMC studies suggest that this in vitro approach is an attractive useful tool to be implemented into the lead optimization step of drug development sc…

PharmacologyDrugChromatographyChemistrymedia_common.quotation_subjecttechnology industry and agricultureQuantitative Structure-Activity Relationshipmacromolecular substancesGeneral Medicinemusculoskeletal systemModels BiologicalPharmacokineticsDrug developmentIonic strengthMicellar liquid chromatographyDrug DiscoveryAnimalsHumansmedia_commonCentral Nervous System AgentsChromatography Micellar Electrokinetic CapillaryMini reviews in medicinal chemistry
researchProduct

Development of predictive retention-activity relationship models of antipsychotic drugs by micellar liquid chromatography

1999

The predictive and interpretative capability of quantitative chromatographic retention-biological activity models is supported by the fact that in adequate experimental conditions the solute partitioning into the chromatographic system can emulate the solute partitioning into lipid bilayers of biological membranes, which is the basis of drug and metabolite uptake, passive transport across membranes and bioaocumulation. The use of micellar solutions of Brij35 as mobile phases in reversed liquid chromatography has proven to be valid in predicting some biological activities of different kinds of drugs. In this paper, the correlations between the logarithm of capacity factors and pharmacokineti…

PharmacologyDrugChromatographyPassive transportChemistrymedia_common.quotation_subjectMetaboliteClinical BiochemistryBiological membraneGeneral MedicineBiochemistryAnalytical Chemistrychemistry.chemical_compoundMembranePharmacokineticsMicellar liquid chromatographyDrug DiscoveryMicellar solutionsMolecular Biologymedia_commonBiomedical Chromatography
researchProduct

Disposition ofd-penicillamine, a promising drug for preventing alcohol-relapse. Influence of dose, chronic alcohol consumption and age: studies in ra…

2014

Pharmacokinetic studies concerning d-penicillamine (an acetaldehyde sequestering agent) are scarce and have not evaluated the influence of chronic ethanol consumption and age on its disposition. Since recent preclinical studies propose d-penicillamine as a promising treatment for alcohol relapse, the main aim of the present work was to evaluate the influence of these two factors on d-penicillamine disposition in order to guide future clinical studies on the anti-relapse efficacy of this drug in alcoholism. Additionally, the effect of the administered dose was also evaluated. To this end, three studies were carried out. Study 1 assessed the influence of dose on d-penicillamine disposition, w…

PharmacologyDrugNot evaluatedEthanolbusiness.industrymedia_common.quotation_subjectPenicillamineAcetaldehydePharmaceutical ScienceAlcoholGeneral MedicineDispositionPharmacologychemistry.chemical_compoundPharmacokineticschemistrymedicinePharmacology (medical)businessmedia_commonmedicine.drugBiopharmaceutics & Drug Disposition
researchProduct

An update on metabolism studies using human hepatocytes in primary culture

2008

Background: Cultured human hepatocytes are the closest in vitro model to human liver and constitute a very predictive model for drug metabolism in vivo. The variability observed in human hepatocytes reflects the existing phenotypic heterogeneity of cytochrome P450 expression in human liver. Objectives: As drug metabolism is the major source of pharmacokinetic variability in human beings, the main areas of current drug metabolism research in human hepatocytes are reviewed. Methods: To speed up the selection of drug candidates, the evaluation of metabolic stability, metabolite profiling and identification, and drug–drug interaction potential are key issues in drug development. Results/conclus…

PharmacologyDrugbiologyMechanism (biology)media_common.quotation_subjectCytochrome P450General MedicinePharmacologyToxicologyIn vitroCytochrome P-450 Enzyme SystemPharmaceutical PreparationsPharmacokineticsDrug developmentIn vivoEnzyme InductionHepatocytesbiology.proteinAnimalsCytochrome P-450 Enzyme InhibitorsHumansEnzyme InhibitorsCells CulturedDrug metabolismmedia_commonExpert Opinion on Drug Metabolism & Toxicology
researchProduct